Research & Development
Academic Report
【Conference presentation】Three group classification of participants based on fully automated plasma β-amyloid measurements to achieve high positive and negative predictive values.
| Presented by: | Kazuto Yamashita1), Masahiro Miura1), Kota Nagai2), David Verbel3), Shigeki Iwanaga1), Toshiyuki Sato1), Tomokazu Yoshida4), Atsushi Iwata5) 1) Central Research Laboratories, Sysmex Corporation 2) Japan and Asia Clinical Development Department, Eisai Co., Ltd. 3) Biostatistics, Eisai Inc. 4) Sysmex Corporation 5) Department of Neurology, Tokyo Metropolitan Geriatric Hospital and Institute of gerontology |
| Academic conference: | 15th Clinical Trials on Alzheimer's Disease (CTAD) |
| Presentation Date: | December 1, 2022 |
| Session: | Poster, Clinical Trials:Biomarkers including plasma（LP84A） |
| Overview of presentation: | Link |
| Notes: | Joint announcement with Sysmex Corporation, Eisai Co., Ltd., and Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology. |
- Information contained in the academic report is current as of the date of the announcement,
but may be subject to change without prior notice.